Bristol Myers Squibb Warns Close to-Time period Influence Due To Generics On 2025 Gross sales Forecast, Outlines $2 Billion In Extra Value Cuts –...
On Thursday, Bristol Myers Squibb & Co BMY posted fourth-quarter revenues of $12.34 billion, beating the consensus of $11.57 billion.
Gross sales elevated 8% year-over-year, or...
Why Is Novo Nordisk Inventory Buying and selling Larger On Friday? – Novo Nordisk (NYSE:NVO)
On Friday, Novo Nordisk A/S NVO introduced interim outcomes from the part 3 FRONTIER3 trial of 70 kids (aged 1-11 years outdated) with hemophilia...
Why Is Neurocrine Biosciences Inventory Buying and selling Decrease On Friday? – Neurocrine Biosciences (NASDAQ:NBIX)
On Thursday, Neurocrine Biosciences Inc. NBIX reported fourth-quarter adjusted EPS of $1.69, larger than the $1.54 reported a 12 months in the past, beating...